2022-04-012023-03-312023-03-31false11875300MCCORMICK & HARRINGTON LIMITED2023-11-03iso4217:GBPxbrli:pure118753002022-04-01118753002023-03-31118753002022-04-012023-03-31118753002021-04-01118753002022-03-31118753002021-04-012022-03-3111875300bus:SmallEntities2022-04-012023-03-3111875300bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3111875300bus:FullAccounts2022-04-012023-03-3111875300bus:PrivateLimitedCompanyLtd2022-04-012023-03-3111875300core:WithinOneYear2023-03-3111875300core:AfterOneYear2023-03-3111875300core:WithinOneYear2022-03-3111875300core:AfterOneYear2022-03-3111875300core:ShareCapital2023-03-3111875300core:SharePremium2023-03-3111875300core:RevaluationReserve2023-03-3111875300core:OtherReservesSubtotal2023-03-3111875300core:RetainedEarningsAccumulatedLosses2023-03-3111875300core:ShareCapital2022-03-3111875300core:SharePremium2022-03-3111875300core:RevaluationReserve2022-03-3111875300core:OtherReservesSubtotal2022-03-3111875300core:RetainedEarningsAccumulatedLosses2022-03-3111875300core:LandBuildings2023-03-3111875300core:PlantMachinery2023-03-3111875300core:Vehicles2023-03-3111875300core:FurnitureFittings2023-03-3111875300core:OfficeEquipment2023-03-3111875300core:NetGoodwill2023-03-3111875300core:IntangibleAssetsOtherThanGoodwill2023-03-3111875300core:ListedExchangeTraded2023-03-3111875300core:UnlistedNon-exchangeTraded2023-03-3111875300core:LandBuildings2022-03-3111875300core:PlantMachinery2022-03-3111875300core:Vehicles2022-03-3111875300core:FurnitureFittings2022-03-3111875300core:OfficeEquipment2022-03-3111875300core:NetGoodwill2022-03-3111875300core:IntangibleAssetsOtherThanGoodwill2022-03-3111875300core:ListedExchangeTraded2022-03-3111875300core:UnlistedNon-exchangeTraded2022-03-3111875300core:LandBuildings2022-04-012023-03-3111875300core:PlantMachinery2022-04-012023-03-3111875300core:Vehicles2022-04-012023-03-3111875300core:FurnitureFittings2022-04-012023-03-3111875300core:OfficeEquipment2022-04-012023-03-3111875300core:NetGoodwill2022-04-012023-03-3111875300core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3111875300core:ListedExchangeTraded2022-04-012023-03-3111875300core:UnlistedNon-exchangeTraded2022-04-012023-03-3111875300core:MoreThanFiveYears2022-04-012023-03-3111875300core:Non-currentFinancialInstruments2023-03-3111875300core:Non-currentFinancialInstruments2022-03-3111875300dpl:CostSales2022-04-012023-03-3111875300dpl:DistributionCosts2022-04-012023-03-3111875300core:LandBuildings2022-04-012023-03-3111875300core:PlantMachinery2022-04-012023-03-3111875300core:Vehicles2022-04-012023-03-3111875300core:FurnitureFittings2022-04-012023-03-3111875300core:OfficeEquipment2022-04-012023-03-3111875300dpl:AdministrativeExpenses2022-04-012023-03-3111875300core:NetGoodwill2022-04-012023-03-3111875300core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3111875300dpl:GroupUndertakings2022-04-012023-03-3111875300dpl:ParticipatingInterests2022-04-012023-03-3111875300dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3111875300core:ListedExchangeTraded2022-04-012023-03-3111875300dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3111875300core:UnlistedNon-exchangeTraded2022-04-012023-03-3111875300dpl:CostSales2021-04-012022-03-3111875300dpl:DistributionCosts2021-04-012022-03-3111875300core:LandBuildings2021-04-012022-03-3111875300core:PlantMachinery2021-04-012022-03-3111875300core:Vehicles2021-04-012022-03-3111875300core:FurnitureFittings2021-04-012022-03-3111875300core:OfficeEquipment2021-04-012022-03-3111875300dpl:AdministrativeExpenses2021-04-012022-03-3111875300core:NetGoodwill2021-04-012022-03-3111875300core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3111875300dpl:GroupUndertakings2021-04-012022-03-3111875300dpl:ParticipatingInterests2021-04-012022-03-3111875300dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3111875300core:ListedExchangeTraded2021-04-012022-03-3111875300dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3111875300core:UnlistedNon-exchangeTraded2021-04-012022-03-3111875300core:NetGoodwill2023-03-3111875300core:IntangibleAssetsOtherThanGoodwill2023-03-3111875300core:LandBuildings2023-03-3111875300core:PlantMachinery2023-03-3111875300core:Vehicles2023-03-3111875300core:FurnitureFittings2023-03-3111875300core:OfficeEquipment2023-03-3111875300core:AfterOneYear2023-03-3111875300core:WithinOneYear2023-03-3111875300core:ListedExchangeTraded2023-03-3111875300core:UnlistedNon-exchangeTraded2023-03-3111875300core:ShareCapital2023-03-3111875300core:SharePremium2023-03-3111875300core:RevaluationReserve2023-03-3111875300core:OtherReservesSubtotal2023-03-3111875300core:RetainedEarningsAccumulatedLosses2023-03-3111875300core:NetGoodwill2022-03-3111875300core:IntangibleAssetsOtherThanGoodwill2022-03-3111875300core:LandBuildings2022-03-3111875300core:PlantMachinery2022-03-3111875300core:Vehicles2022-03-3111875300core:FurnitureFittings2022-03-3111875300core:OfficeEquipment2022-03-3111875300core:AfterOneYear2022-03-3111875300core:WithinOneYear2022-03-3111875300core:ListedExchangeTraded2022-03-3111875300core:UnlistedNon-exchangeTraded2022-03-3111875300core:ShareCapital2022-03-3111875300core:SharePremium2022-03-3111875300core:RevaluationReserve2022-03-3111875300core:OtherReservesSubtotal2022-03-3111875300core:RetainedEarningsAccumulatedLosses2022-03-3111875300core:NetGoodwill2021-04-0111875300core:IntangibleAssetsOtherThanGoodwill2021-04-0111875300core:LandBuildings2021-04-0111875300core:PlantMachinery2021-04-0111875300core:Vehicles2021-04-0111875300core:FurnitureFittings2021-04-0111875300core:OfficeEquipment2021-04-0111875300core:AfterOneYear2021-04-0111875300core:WithinOneYear2021-04-0111875300core:ListedExchangeTraded2021-04-0111875300core:UnlistedNon-exchangeTraded2021-04-0111875300core:ShareCapital2021-04-0111875300core:SharePremium2021-04-0111875300core:RevaluationReserve2021-04-0111875300core:OtherReservesSubtotal2021-04-0111875300core:RetainedEarningsAccumulatedLosses2021-04-0111875300core:AfterOneYear2022-04-012023-03-3111875300core:WithinOneYear2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3111875300core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3111875300core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3111875300core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3111875300core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3111875300core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3111875300bus:Director12022-04-012023-03-3111875300bus:Director22022-04-012023-03-3111875300core:FurnitureFittingsToolsEquipment2022-03-3111875300core:FurnitureFittingsToolsEquipment2022-04-012023-03-3111875300core:FurnitureFittingsToolsEquipment2023-03-31

MCCORMICK & HARRINGTON LIMITED

Registered Number
11875300
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

MCCORMICK & HARRINGTON LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

HARRINGTON, Craig
MCCORMICK, Neal James

Registered Address

Billingham Dental
69-71 Queensway
Billingham
TS3 2LU

Registered Number

11875300 (England and Wales)
MCCORMICK & HARRINGTON LIMITED
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets8230,800241,541
230,800241,541
Current assets
Stocks1011,1397,905
Debtors1159,34158,558
Cash at bank and on hand102,260109,806
172,740176,269
Creditors amounts falling due within one year12(217,214)(153,612)
Net current assets (liabilities)(44,474)22,657
Total assets less current liabilities186,326264,198
Creditors amounts falling due after one year13(88,772)(171,835)
Net assets97,55492,363
Capital and reserves
Called up share capital100100
Profit and loss account97,45492,263
Shareholders' funds97,55492,363
The financial statements were approved and authorised for issue by the Board of Directors on 3 November 2023, and are signed on its behalf by:
HARRINGTON, Craig
Director
MCCORMICK, Neal James
Director

Registered Company No. 11875300
MCCORMICK & HARRINGTON LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company during the year was dentistry.
4.Basis of measurement used in financial statements
The financial statements have been prepared under the historical cost basis.
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Stocks policy
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatments uncompleted at the year end date is recognised by reference to the stage of completion.
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Leases policy
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
Valuation of financial instruments policy
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of is liabilities.
6.Prior reporting period impact on current profit and loss
Following the challenges arising as a consequence of the Covid-19 pandemic in 2020/21, more latterly the UK economy has been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company’s trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it, and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
7.Employee information

20232022
Average number of employees during the year1312
8.Property, plant and equipment

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 2242,791349,6802,74317,252412,466
Additions--94936,80437,753
At 31 March 2342,791349,6803,69254,056450,219
Depreciation and impairment
At 01 April 22-161,7951,1607,970170,925
Charge for year-38,7705079,21748,494
At 31 March 23-200,5651,66717,187219,419
Net book value
At 31 March 2342,791149,1152,02536,869230,800
At 31 March 2242,791187,8851,5839,282241,541
9.Description of nature of transactions and balances with related parties
During the year the company loaned the Directors £734 (2022: £410). This loan was interest free and repayable upon demand. The balance of this loan is included in other creditors.
10.Stocks

2023

2022

££
Raw materials and consumables11,1397,905
Total11,1397,905
11.Debtors

2023

2022

££
Trade debtors / trade receivables59,34158,558
Total59,34158,558
12.Creditors within one year

2023

2022

££
Trade creditors / trade payables66,28945,329
Bank borrowings and overdrafts59,80550,648
Taxation and social security46,84029,863
Finance lease and HP contracts23,25816,713
Other creditors734410
Accrued liabilities and deferred income20,28810,649
Total217,214153,612
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
13.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts38,18097,986
Other creditors50,59273,849
Total88,772171,835
14.Finance lease and HP contracts after one year

2023

2022

££
Finance lease and HP contracts50,59273,850
15.Provisions for liabilities